Which hospital in Wuxi has a better hematology department?

The Department of Hematology of People's Hospital should be the most professional in Wuxi.

Related information:

Hematology Department of Wuxi People's Hospital is a key clinical specialty in Jiangsu Province, which has obvious advantages in talent team, technology and equipment, and is also at an advanced level in the province. The department has 69 specialist beds, including 5 first-class laminar aseptic wards in China, which treat about 80% patients with hematological diseases in the city every year. The department is equipped with a blood laboratory, with advanced instruments and equipment such as flow cell room, molecular biology laboratory, cell culture room, cytogenetics room, blood cell separator and low-temperature program-controlled freezer. At present, there are more than 40 medical staff, including provincial "135" and "333" project training objects. In recent years, it has won the honorary titles of Jiangsu May 1st Labor Award, Jiangsu Youth Civilization and Women's Demonstration Post.

Hematology focuses on the diagnosis and treatment of acute and chronic leukemia, malignant lymphoma, multiple myeloma and myelodysplastic syndrome. At the same time, he has rich experience in the diagnosis and treatment of various anemia, platelet diseases and hemorrhagic diseases, and has successfully rescued countless patients with difficult blood diseases. Mature autologous and allogeneic hematopoietic stem cell transplantation enables patients with leukemia and lymphoma to survive for a long time. In the treatment of acute and chronic leukemia, various chemotherapy schemes have made the remission rate reach more than 80%, and the induced differentiation treatment of acute promyelocytic leukemia has saved patients from the pain and huge cost of bone marrow transplantation. Application of advanced monoclonal antibodies in biological targeted therapy of hematological malignancies. The application of immunosuppressive drugs in the treatment of aplastic anemia has also achieved good results.

The hematology department has carried out the cytomorphology of leukemia and other malignant hematological diseases, carried out the cytogenetic examination of chromosomes, and carried out the molecular biological examination including fusion genes and oncogenes of malignant hematological diseases by flow cytometry and PCR, which can collect, freeze and clinically apply hematopoietic stem cells.

The hematology department is carrying out basic and clinical research on immunotherapy with malignant hematological diseases as the mainstay, hoping to further reduce the tumor burden of malignant hematological diseases through activated dendritic cells or leukemia vaccines and make efforts to finally eradicate malignant hematological diseases. Hematology department will further cultivate and introduce talents, constantly explore new areas of diagnosis and treatment of hematological diseases, expand its influence and scale, and build a first-class hematology specialty and discipline in the province.

In recent five years, the research projects such as "Study on the Expression and Correlation of Telomerase, Chromosome and P 170 in Acute Leukemia" and "Study on Drug Resistance Phenotype and Genotype of Common Pathogens in Wuxi" won the second prize of Wuxi Science and Technology 1 and the second prize of Wuxi Science and Technology respectively. The application of ETO/AMLI and Bcr/Abl fusion genes in leukemia, allogeneic hematopoietic stem cell transplantation for leukemia and other new technologies won the second prize of Jiangsu Province 1, the first prize of Wuxi City, and the second prize of Wuxi City.